Prosecution Insights
Last updated: August 06, 2026

K&L Gates Llp-Boston

22 pending office actions • 15 clients • 21 examiners • 17 art units • 0 of 22 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Quality Metrics (n=34052 apps, methodology: how we score firms)

84.7%
Allowance Rate
n=34052
+0.65σ
Allowance Rate (norm)
n=34052
3.8
OAs to Allowance
n=20482
+0.04σ
OAs to Allow (norm)
n=20482
1083 days
Time to Allowance
n=20482
+8.9pp
Interview Lift
n=34052
32.7%
RCE Rate
n=34052
2.8%
Appeal Rate
n=34052

Rejection Performance (% of received rejections ultimately overcome)

76.3%
§101 Overcome
n=2410
77.8%
§102 Overcome
n=8886
78.3%
§103 Overcome
n=15071
78.6%
§112 Overcome
n=10307

Specialization & Scale

A61K, G06F, H01M
Top CPC Subclasses
13%
Top-3 CPC Share
n=34052
88
Practitioners
n=34052
387.0
Apps / Practitioner
n=34052

Portfolio Summary

22
Total Pending OAs
13
Non-Final OAs
8
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
4
Due this month
3
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (4)Due ≤ 60 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

13
Hard (59%)
8
Medium (36%)
1
Easy (5%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (9%)
§101 + other1 (5%)
§103 only6 (27%)
§102 only1 (5%)
§112 only1 (5%)
Double-patenting + other1 (5%)
Multi-statute (no §101)10 (45%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
68% of docket
1
Information Tech
5% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
18% of docket
2
Business / Other
9% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

220 h
Manual time on pending OAs
44 h
Time saved (low, 20%)
77 h
Time saved (mid, 35%)
1.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HUDSON, AMY ROSE 2 75.0% +11.4%
FETTEROLF, BRANDON J 1 51.4% +17.1%
NORRIS, CLAIRE A 1 65.7% +28.1%
MCMILLIAN, KARA RENITA 1 30.4% +37.9%
VETTER, DANIEL 1 19.6% +8.9%
INAM, SAHAR 1 100.0% +0.0%
GILL, RACHEL B 1 65.5% +27.9%
HOPKINS, SAMANTHA LAKE 1 56.8% +67.9%
SHIN, DANA H 1 27.0% +27.4%
KOMATSU, LI N 1 59.6% +71.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18292582 METHODS OF TREATING CANCER INAM, SAHAR

Hard Cases (14)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17730900 Automated Healthcare Provider Quality Reporting System (PQRS) HEIN, DEVIN C 99d overdue
18643059 MAGNETIC FILTER APPARATUS AND METHOD NORRIS, CLAIRE A 60d overdue
18596511 SKILL LEVEL INFERENCE USING MACHINE LEARNING VETTER, DANIEL 25d overdue
16507521 METHOD AND SYSTEM TO AUTOMATE THE DESIGNATION OF THE INTERNATIONAL CLASSIFICATION OF DISEASE CODES FOR A PATIENT PAULS, JOHN A 11d overdue
17927497 MEMBRANE EMULSIFICATION APPARATUS WITH REFINER AND METHOD OF PREPARING A REFINED EMULSION BASS, DIRK R 12d
18025307 SENOLYTIC COMPOUNDS AND COMPOSITIONS ROBINSON, MIKHAIL O'DONNEL 14d
18248988 NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR VANHORN, ABIGAIL LOUISE 20d
18016143 METHOD OF PREPARING LIPID VESICLES SHOMER, ISAAC 20d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18643059 MAGNETIC FILTER APPARATUS AND METHOD NORRIS, CLAIRE A 60d overdue
18420532 FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS GILL, RACHEL B 46d
18037505 ERYTHROPOIETIN VARIANTS AND USES THEREOF KOMATSU, LI N 56d
18781151 FIRST IN CLASS USE OF ESTROGEN RECEPTOR BETA AGONISTS IN TREATING ANGELMAN SYNDROME AND RELEVANT AUTISM SPECTRUM DISORDERS FETTEROLF, BRANDON J
18633164 COMBINATION OF BI853520 WITH CHEMOTHERAPEUTIC DRUGS MCMILLIAN, KARA RENITA
18037884 CONJUGATE AND USE THEREOF HOPKINS, SAMANTHA LAKE
18319705 LIPID-BASED TOPICAL INJECTION FORMULATIONS SHIN, DANA H
18248982 NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3 HUDSON, AMY ROSE

Client Portfolio (15 clients)

Top Art Units

Art UnitApps
16363
17792
36281
16221
16711
16411
16351
16581
16271
21131

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18781151 FIRST IN CLASS USE OF ESTROGEN RECEPTOR BETA AGONISTS IN TREATING ANGELMAN SYNDROME AND RELEVANT AUTISM SPECTRUM DISORDERS Brown University FETTEROLF, BRANDON J §103 Non-Final OA Pending Jul 23, 2024
18643059 MAGNETIC FILTER APPARATUS AND METHOD Medisieve Ltd. NORRIS, CLAIRE A 1779 §102§103 Final Rejection 60d overdue Pending Apr 23, 2024
18633164 COMBINATION OF BI853520 WITH CHEMOTHERAPEUTIC DRUGS Inxmed (Nanjing) Co., Ltd. MCMILLIAN, KARA RENITA §102§103§112Other Non-Final OA Pending Apr 11, 2024
18596511 SKILL LEVEL INFERENCE USING MACHINE LEARNING Skyhive Technologies Holdings Inc. VETTER, DANIEL 3628 §101 Final Rejection 25d overdue Pending Mar 05, 2024
18292582 METHODS OF TREATING CANCER Foghorn Therapeutics Inc. INAM, SAHAR 1622 §103 Non-Final OA Pending Jan 26, 2024
18420532 FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS VISTERRA, INC. GILL, RACHEL B 1671 §102 Non-Final OA 46d Pending Jan 23, 2024
18037884 CONJUGATE AND USE THEREOF Nanjing Chempion Biotechnology Co., Ltd. HOPKINS, SAMANTHA LAKE 1641 §103§112 Non-Final OA Pending May 19, 2023
18319705 LIPID-BASED TOPICAL INJECTION FORMULATIONS Hangzhou Jitai Pharmaceutical Technology Co., Ltd. SHIN, DANA H 1635 §102§112DP Non-Final OA Pending May 18, 2023
18037505 ERYTHROPOIETIN VARIANTS AND USES THEREOF Chulabhorn Foundation KOMATSU, LI N 1658 §102§103§112 Non-Final OA 56d Pending May 17, 2023
18248982 NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3 Sanofi HUDSON, AMY ROSE 1636 §102§103§112 Final Rejection Pending Apr 13, 2023
18248988 NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR Sanofi VANHORN, ABIGAIL LOUISE 1636 §103§112Other Final Rejection 20d Pending Apr 13, 2023
18025307 SENOLYTIC COMPOUNDS AND COMPOSITIONS Nuchido Limited ROBINSON, MIKHAIL O'DONNEL 1627 §103§112 Non-Final OA 14d Pending Mar 08, 2023
18106550 HIGH RELIABILITY FAULT TOLERANT COMPUTER ARCHITECTURE Stratus Technologies Ireland Ltd. XU, MICHAEL 2113 §103 Non-Final OA Pending Feb 07, 2023
18018078 METHODS OF PREPARING SOLID PARTICULATE MATERIALS Micropore Technologies Limited HUANG, RYAN 1777 §103 Final Rejection 107d overdue Pending Jan 26, 2023
18016143 METHOD OF PREPARING LIPID VESICLES Micropore Technologies Limited SHOMER, ISAAC 1612 §103§112 Non-Final OA 20d Pending Jan 13, 2023
17927497 MEMBRANE EMULSIFICATION APPARATUS WITH REFINER AND METHOD OF PREPARING A REFINED EMULSION Micropore Technologies Limited BASS, DIRK R 1779 §102§103 Final Rejection 12d Pending Nov 23, 2022
17730900 Automated Healthcare Provider Quality Reporting System (PQRS) Modernizing Medicine, Inc. HEIN, DEVIN C 3686 §101§103 Non-Final OA 99d overdue Pending Apr 27, 2022
17638339 COMPOSITIONS AND METHODS FOR INHIBITING PCSK9 Sanofi HUDSON, AMY ROSE 1636 §102§103 Non-Final OA Pending Feb 25, 2022
16980207 METHOD OF TREATMENT Nuchido Limited OLSON, ANDREA STEFFEL 1693 §103 Final Rejection 73d overdue Pending Sep 11, 2020
16849141 Apparatus and Method for Assessment of Patient Condition Modernizing Medicine, Inc. NAJARIAN, LENA 3687 §103 Non-Final OA 34d Pending Apr 15, 2020
16631861 METHODS AND COMPOSITIONS FOR TREATING ADDICTIONS BAR ILAN UNIVERSITY VIVLEMORE, TRACY ANN 1638 §112 Final Rejection 3d overdue Pending Jan 17, 2020
16507521 METHOD AND SYSTEM TO AUTOMATE THE DESIGNATION OF THE INTERNATIONAL CLASSIFICATION OF DISEASE CODES FOR A PATIENT Modernizing Medicine, Inc. PAULS, JOHN A 3683 §101 Non-Final OA 11d overdue Pending Jul 10, 2019

Managing K&L Gates Llp-Boston's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month